Cas 355836-06-5,2-sec-butylsulfanyl-3-ethyl-6-methoxy-5-(2-methoxy-4-trifluoromethoxy-phenyl)-pyrazine

355836-06-5

Post Buying Request

Basic information

Product Name: 2-sec-butylsulfanyl-3-ethyl-6-methoxy-5-(2-methoxy-4-trifluoromethoxy-phenyl)-pyrazine
Synonyms:
CAS NO:355836-06-5
Molecular Formula:
Molecular Weight: 416.464
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: 2-sec-butylsulfanyl-3-ethyl-6-methoxy-5-(2-methoxy-4-trifluoromethoxy-phenyl)-pyrazine(CAS DataBase Reference)
NIST Chemistry Reference: 2-sec-butylsulfanyl-3-ethyl-6-methoxy-5-(2-methoxy-4-trifluoromethoxy-phenyl)-pyrazine(355836-06-5)
EPA Substance Registry System: 2-sec-butylsulfanyl-3-ethyl-6-methoxy-5-(2-methoxy-4-trifluoromethoxy-phenyl)-pyrazine(355836-06-5)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 355836-06-5(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

355836-06-5 Suppliers

Recommended suppliers

355836-06-5 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 355836-06-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,5,5,8,3 and 6 respectively; the second part has 2 digits, 0 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 355836-06:
(8*3)+(7*5)+(6*5)+(5*8)+(4*3)+(3*6)+(2*0)+(1*6)=165
165 % 10 = 5
So 355836-06-5 is a valid CAS Registry Number.

355836-06-5Upstream product

355836-38-3 [4-(5-bromo-6-ethyl-3-methoxypyrazin-2-yl)-3-methoxyphenoxy]trifluoromethane

355836-06-5Downstream Products

355836-06-5Relevant academic research and scientific papers

SUBSTITUTED ARYLPYRAZINES

-

, (2008/06/13)

Arylpyrazine compounds are provided, including arylpyrazines that can bind with high affinity and high selectivity to CRF1 receptors, including human CRF1 receptors. The invention thus includes methods for treatment of disorders and diseases associated with CRF1 receptors, including CNS-related disorders and diseases, particularly affective disorders and diseases, and acute and chronic neurological disorders and diseases.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 355836-06-5